Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011386
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical support, manufacturing support and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to global pharmaceutical companies, biotechnology companies, government agencies, as well as leading hospitals and academic institutions, and operates through a network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc (CRL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Charles River Laboratories International Inc, Medical Equipment, Deal Details 12
Partnerships 12
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 17
Charles River Labs Enters Into Agreement With Bruker For Axcess System 18
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 19
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson’s Disease 20
BioFocus Enters Into An Agreement With Almac Group 21
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 22
Asset Transactions 23
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Acquisition 24
Charles River Labs Acquires Celsis International for USD214.5 Million 24
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 25
Charles River Laboratories International Inc – Key Competitors 26
Charles River Laboratories International Inc – Key Employees 27
Charles River Laboratories International Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 33
Financial Announcements 33
Nov 09, 2017: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations 33
Aug 09, 2017: Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations 35
May 10, 2017: Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations 37
Feb 14, 2017: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance 39
Nov 02, 2016: Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations 42
Aug 03, 2016: Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations 44
May 04, 2016: Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations 46
Feb 10, 2016: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance 48
Corporate Communications 51
Jul 05, 2017: Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of Directors 51
Product News 52
Nov 01, 2017: Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017 52
Other Significant Developments 54
Dec 06, 2017: Charles River Adds ERS License to CRISPR/Cas9 Service Offering 54
Jun 28, 2017: SenzaGen signs global distribution agreement with Charles River Laboratories 55
May 16, 2017: Charles River Laboratories Announces Updates to Oncology Business 56
Sep 29, 2016: PathoQuest Announces Partnership with Charles River Laboratories 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Charles River Laboratories International Inc, Medical Equipment, Key Facts, 2016 2
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Deals By Market, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 17
Charles River Labs Enters Into Agreement With Bruker For Axcess System 18
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 19
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease 20
BioFocus Enters Into An Agreement With Almac Group 21
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 22
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Charles River Labs Acquires Celsis International for USD214.5 Million 24
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 25
Charles River Laboratories International Inc, Key Competitors 26
Charles River Laboratories International Inc, Key Employees 27
Charles River Laboratories International Inc, Subsidiaries 29

★海外企業調査レポート[Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sientra Inc (SIEN):企業の財務・戦略的SWOT分析
    Summary Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices suc …
  • Iwatani Corporation (8088):企業の財務・戦略的SWOT分析
    Iwatani Corporation (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Vodacom Group Ltd (VOD):企業の財務・戦略的SWOT分析
    Vodacom Group Ltd (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Daiho Corporation:企業の戦略・SWOT・財務情報
    Daiho Corporation - Strategy, SWOT and Corporate Finance Report Summary Daiho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MiaSole Hi-Tech Corp:電力:M&Aディール及び事業提携情報
    Summary MiaSole Hi-Tech Corp (MiaSole) is an alternative energy company that manufactures, designs, develops, and markets thin-film photovoltaic solar cells and panels. The company's products include flexible solar cells, custom modules and SolarRide. It offers photovoltaic products for large-scale …
  • RSA Insurance Group plc:企業のM&A・事業提携・投資動向
    RSA Insurance Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RSA Insurance Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Volta River Authority:発電所・企業SWOT分析
    Volta River Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Liberty House Group:企業の戦略・SWOT・財務情報
    Liberty House Group - Strategy, SWOT and Corporate Finance Report Summary Liberty House Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BBA Aviation plc (BBA):企業の財務・戦略的SWOT分析
    BBA Aviation plc (BBA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Celonic AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that offers contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of acti …
  • Assembly Biosciences Inc (ASMB)-製薬・医療分野:企業M&A・提携分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that discover, develops and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as chronic hepatitis B virus (HBV) and microbioti …
  • Danubius Hotel and Spa Private Company Limited:企業の戦略・SWOT・財務情報
    Danubius Hotel and Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel and Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • National University of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary National University of Singapore (NUS) is an educational university that offers research and training services. The university provides undergraduate, graduate and double degree programmes. It offers programs in the areas of arts and social sciences, business, computing, dentistry, design an …
  • Simons Group Ltd:企業の戦略・SWOT・財務分析
    Simons Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Simons Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Immco Diagnostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary IMMCO Diagnostics Inc (IMMCO), a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also deve …
  • Morphotek Inc:企業のM&A・事業提携・投資動向
    Morphotek Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Morphotek Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Intuitive Surgical Inc (ISRG):医療機器:M&Aディール及び事業提携情報
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The d …
  • Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆